43 related articles for article (PubMed ID: 19194828)
1. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
Fang C; Wei XM; Zeng XT; Wang FB; Weng H; Long X
BMC Cancer; 2015 Nov; 15():920. PubMed ID: 26585467
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.
Shakeri H; Gharesouran J; Fakhrjou A; Esfahani A; Mohaddes Ardebili SM
EXCLI J; 2016; 15():11-20. PubMed ID: 27065772
[TBL] [Abstract][Full Text] [Related]
3. Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis.
Schnekenburger M; Karius T; Diederich M
Front Pharmacol; 2014; 5():170. PubMed ID: 25076909
[TBL] [Abstract][Full Text] [Related]
4. An Optimized CoBRA Method for the Microfluidic Electrophoresis Detection of Breast Cancer Associated
Aibel C; Coll De Peña A; Tripathi A
BioTech (Basel); 2023 Jan; 12(1):. PubMed ID: 36648833
[TBL] [Abstract][Full Text] [Related]
5. The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.
Li S; He Y; Li C; Liu X; Shen Y; Wu Y; Bai N; Li Q
Medicine (Baltimore); 2020 Mar; 99(10):e19345. PubMed ID: 32150073
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
Qi M; Xiong X
Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 carriers with male breast cancer show elevated tumour methylation.
Deb S; Gorringe KL; Pang JB; Byrne DJ; Takano EA; ; Dobrovic A; Fox SB
BMC Cancer; 2017 Sep; 17(1):641. PubMed ID: 28893223
[TBL] [Abstract][Full Text] [Related]
8. Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.
Zhang L; Long X
Sci Rep; 2015 Dec; 5():17869. PubMed ID: 26643130
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk variants associated with in situ breast cancer.
Campa D; Barrdahl M; Gaudet MM; Black A; Chanock SJ; Diver WR; Gapstur SM; Haiman C; Hankinson S; Hazra A; Henderson B; Hoover RN; Hunter DJ; Joshi AD; Kraft P; Le Marchand L; Lindström S; Willett W; Travis RC; Amiano P; Siddiq A; Trichopoulos D; Sund M; Tjønneland A; Weiderpass E; Peeters PH; Panico S; Dossus L; Ziegler RG; Canzian F; Kaaks R
Breast Cancer Res; 2015 Jun; 17(1):82. PubMed ID: 26070784
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
Otani Y; Miyake T; Kagara N; Shimoda M; Naoi Y; Maruyama N; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Cancer Sci; 2014 Oct; 105(10):1369-76. PubMed ID: 25155055
[TBL] [Abstract][Full Text] [Related]
11. Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.
Jung EJ; Kim IS; Lee EY; Kang JE; Lee SM; Kim DC; Kim JY; Park ST
Ann Lab Med; 2013 Nov; 33(6):431-40. PubMed ID: 24205493
[TBL] [Abstract][Full Text] [Related]
12. Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients.
Majchrzak-Celińska A; Paluszczak J; Kleszcz R; Magiera M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Appl Genet; 2013 Aug; 54(3):335-44. PubMed ID: 23661397
[TBL] [Abstract][Full Text] [Related]
13. Methylation of tumor suppressor genes in ovarian cancer.
Ozdemir F; Altinisik J; Karateke A; Coksuer H; Buyru N
Exp Ther Med; 2012 Dec; 4(6):1092-1096. PubMed ID: 23226780
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.
Lotsari JE; Gylling A; Abdel-Rahman WM; Nieminen TT; Aittomäki K; Friman M; Pitkänen R; Aarnio M; Järvinen HJ; Mecklin JP; Kuopio T; Peltomäki P
Breast Cancer Res; 2012 Jun; 14(3):R90. PubMed ID: 22691310
[TBL] [Abstract][Full Text] [Related]
15. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases.
Stuppia L; Antonucci I; Palka G; Gatta V
Int J Mol Sci; 2012; 13(3):3245-3276. PubMed ID: 22489151
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer.
Cabello MJ; Grau L; Franco N; Orenes E; Alvarez M; Blanca A; Heredero O; Palacios A; Urrutia M; Fernández JM; López-Beltrán A; Sánchez-Carbayo M
J Mol Diagn; 2011 Jan; 13(1):29-40. PubMed ID: 21227392
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.
Castro M; Grau L; Puerta P; Gimenez L; Venditti J; Quadrelli S; Sánchez-Carbayo M
J Transl Med; 2010 Sep; 8():86. PubMed ID: 20849603
[TBL] [Abstract][Full Text] [Related]
18. Methylation profiles in breast cancer.
Buyru N; Altinisik J; Ozdemir F; Demokan S; Dalay N
Cancer Invest; 2009 Mar; 27(3):307-12. PubMed ID: 19194828
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
